WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Ownership - Who owns Arcutis Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcutis Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Masaru MatsudaCLO;EVP2026-09-163,674$25.00
$91.85kSell
Howard G. WelgusDirector2026-09-152,255$8.63
$19.46kBuy
Howard G. WelgusDirector2026-09-154,730$24.18
$114.37kSell
Howard G. WelgusDirector2026-09-151,019$7.51
$7.65kBuy
Howard G. WelgusDirector2026-09-15822$6.52
$5.36kBuy
Masaru MatsudaCLO;EVP2026-09-089,989$25.03
$249.98kSell
Terrie CurranDirector2026-08-2727,052$8.63
$233.46kBuy
Terrie CurranDirector2026-08-2727,052$25.03
$677.08kSell
Terrie CurranDirector2026-08-2711,148$25.03
$279.02kSell
Terrie CurranDirector2026-08-2711,148$7.51
$83.72kBuy

1 of 12

ARQT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARQT insiders and whales buy or sell their stock.

ARQT Shareholders

What type of owners hold Arcutis Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Heron15.46%19,436,232$493.29MInsider
Frazier Life Sciences VIII LP7.03%8,838,534$224.32MInsider
Bain Capital Life Sciences Investors LLC3.17%3,979,292$100.99MInsider
Todd Franklin Watanabe0.87%1,095,430$27.80MInsider
Todd Watanabe0.86%1,081,831$27.46MInsider
Bhaskar Chaudhuri0.73%917,807$23.29MInsider
Jonathan Silverstein0.72%902,286$22.90MInsider
Orbimed Advisors LLC0.33%415,142$10.54MInsider
David W. Osborne0.26%331,332$8.41MInsider
Christopher Peetz0.15%191,815$4.87MInsider

1 of 3

ARQT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARQT0.10%30.68%Net SellingNet Selling
DYN0.10%20.12%Net SellingNet Selling
VCYT0.11%53.43%Net SellingNet Selling
RCUS0.10%44.15%Net SellingNet Selling
DNLI0.10%57.28%Net SellingNet Selling
View Top Biotech Stocks

Arcutis Biotherapeutics Stock Ownership FAQ

Who owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics (NASDAQ: ARQT) is owned by 0.10% institutional shareholders, 30.68% Arcutis Biotherapeutics insiders, and 69.22% retail investors. Patrick J. Heron is the largest individual Arcutis Biotherapeutics shareholder, owning 19.44M shares representing 15.46% of the company. Patrick J. Heron's Arcutis Biotherapeutics shares are currently valued at $493.29M.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.